Germany and France pull Takeda's diabetes pill Actos from market

06/9/2011 | Wall Street Journal, The · Reuters

French and German regulators are banning Takeda Pharmaceutical's diabetes medicine Actos in light of an epidemiological study linking the drug, also known as pioglitazone, to an increased risk of bladder cancer. U.S. officials did not indicate a plan to follow suit, Takeda said.

View Full Article in:

Wall Street Journal, The · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA